Muller & Phipps (India) Limited (MULLER.BO)
BSE · INR · Healthcare · Pharmaceutical Retailers
₹195.00 (+0.00%) as of
Key statistics
- Market cap
- 121.88M
- EPS (TTM)
- -10.10
- Dividend yield
- 0.00%
- 52-week range
- 188.10 – 264.00
- Beta
- -0.61
- Revenue (TTM)
- 67.05M
- Profit margin
- -9.40%
- Volume
- 2.00
About Muller & Phipps (India) Limited
Muller & Phipps (India) Limited markets and distributes over the counter medical preparation and home care products in India. The company sells medicated dental cream, gel, and gum astringent products under the Cavisan brand; dental and skincare products under the Cavidine and Nixoderm brand name. It markets its products through a network of chemists, general stores, provisional/kirana stores, and supermarkets. The company was incorporated in 1917 and is headquartered in Mumbai, India. The Muller & Phipps (India) Limited is a subsidiary of Development Holding Asia Ltd.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Headquarters
- Mumbai, India
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.
Related stocks
- HARMONY CAPITAL SERVICES LTD. (HRMNYCP.BO)
- AJWA FUN WORLD & RESORT LTD. (AJWAFUN.BO)
- SHRI RAJIVLOCHAN OIL EXTRACTIO (SHRAJOI.BO)
- SOUTHERN INFOCONSULTANTS LIMIT (SOUTHERNIN.BO)
- THIRANI PROJECTS LTD (TPROJECT.BO)
- WILLIAMSON FINANCIAL SERVICES (WILLIMFI.BO)
- Axis Mutual Fund (AXSENSEX.BO)
- SW INVESTMENTS LTD (SW1.BO)